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Abstract Lactase-phlorizin hydrolase (LPH) (EC 3.2.1.23/62), 
a major glycoprotein of the microvillus membrane of human 
small intestinal epithelial cells (enterocytes), is vital for the 
digestion of lactose during early infancy. The enzyme is 
synthesized in enterocytes as a single-chain precursor and 
subsequently proteolytically processed to the mature microvillus 
membrane-bound form. Because it has been reported that COS-1 
cells were not able to proteolytically process LPH to the mature 
protein, these cells have been used as a model system to study 
potential roles of different proteases. COS-1 cells transfected 
with a full-length cDNA for human LPH synthesized enzyma-
tically active enzyme. Immunoprecipitation of the expressed 
glycoproteins and their subsequent analysis by SDS-PAGE 
showed synthesis of two polypeptide species having apparent 
molecular masses of 210 and 220 kDa, respectively, correspond-
ing to the high-mannose (pro-LPHh) form and the complex 
glycosylated (pro-LPHc) form of the LPH precursor. Surpris-
ingly, an additional polypeptide species corresponding in size to 
the mature LPH found in human intestinal cells was also 
detected after longer chase periods. The source of this species 
was clearly pro-LPH, as its formation was inhibited by 
Brefeldin A. The cleaved form of LPH was not found on the 
cell surface; furthermore, its formation was prevented by an 
inhibitor of lysosomal function. We conclude from these data 
that in transfected COS-1 cells pro-LPH is transported to the 
cell surface, from which it is internalised and enters the lysosomal 
pathway, where proteolytic cleavage leads to a molecule not 
unlike mature LPH. 
© 1997 Federation of European Biochemical Societies 
1. Introduction 
Lactase-phlorizin hydrolase (LPH) (EC 3.2.1.23/62), an in-
tegral glycoprotein of the microvillus membrane of small in-
testinal epithelial cells, is responsible for the hydrolysis of 
lactose to its constituent monosaccharides. In enterocytes, 
LPH is synthesized as a single-chain precursor, pro-LPH 
(Mr = 215-245 kDa), which undergoes proteolytic processing 
to yield the mature microvillus membrane form, m-LPH 
{Mr — 160 kDa) [1-4]. The complete primary structure of rab-
bit and human pro-LPH has been deduced from cDNA clon-
ing[5]. 
A number of studies have been published on the processing 
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of lactase in organ cultured rat [3], pig [2] and human [4] 
mucosa. Buller et al. suggested that in rat intestine LPH proc-
essing is a two-step cleavage event, with the first cleavage 
taking place intracellularly and the second after insertion 
into the microvillus membrane. In pig [2] and in human in-
testine this proteolytic cleavage takes place intracellularly pri-
or to insertion into the microvillus membrane [4]. In a human 
intestinal cell line, Caco-2, and in intestinal explants in organ 
culture, proteolytic processing of pro-LPH was shown to oc-
cur after passage of the precursor through the Golgi complex 
[6]. Surface immunoprecipitation of LPH from Madin Darby 
canine kidney (MDCK)-17 cells, which permanently expressed 
human LPH, demonstrated that LPH-processing occurs after 
sorting and is not necessary for surface expression [7]. 
Transfected COS-1 cells are a widely used model to study 
expression of eukaryotic proteins. Transfected with cDNA 
encoding human LPH, COS-1 cells have been reported to 
lack the processing enzymes responsible for maturation of 
LPH [8]. These cells thus promised to be a good model to 
investigate potential LPH-processing proteases. 
We transiently transfected COS-1 cells with a full-length 
cDNA encoding human LPH precursor. Surprisingly, our 
data with LPH cDNA-transfected COS-1 cells show that hu-
man LPH is proteolytically processed in these cells to a mol-
ecule similar in size to mature LPH. This process was depend-
ent on surface expression of pro-LPH and was arrested by an 
inhibitor of lysosomal function. The data further show that a 
partially hydrolysed LPH such as the mature enzyme is very 
resistant to further degradation, a property which helps the 
enzyme survive in the hostile environment of the duodenum. 
2. Materials and methods 
2.1. Reagents and materials 
L-[35S]methionine (1000 Ci/mmol) was from DuPont NEN. All 
SDS-PAGE chemicals were purchased from BioRad Laboratories. 
Endoglycosidase H (endo H) and endoglycosidase F/N-glycosidase 
F (endo F/GF) were purchased from Boehringer Mannheim. Protein 
A-Sepharose®> CL-4B was purchased from Pharmacia. Brefeldin A 
(BFA), bovine serum albumin (BSA), phenylmethane sulphonyl fluo-
ride (PMSF), pepstatin, aprotinin, leupeptin, benzamidine and high 
molecular mass protein standards (cat. #SDS-6H) were from Sigma. 
Cell culture media, penicillin and streptomycin were obtained from 
Gibco BRL. Fetal calf serum (FCS) was from Biological Industries. 
All other chemicals were analytical grade from Merck. The pRB-lH 
vector containing the full-length cDNA coding for LPH was kindly 
provided by Dr. Ned Mantei and Rahel Banzinger (Swiss Federal 
Institute of Technology, Zurich). 
2.2. Determination of lactase activity in COS-1 cells 
Two days post-transfection the COS-1 cells were harvested to de-
termine lactase activity. First, cells grown in a 10 cm petri dish were 
washed twice in ice-cold PBS and then scraped with a rubber spatula 
in 1 ml of Tris-mannitol buffer. Cells were sonicated 20-30 s (homo-
genate). Rupture of the cells was checked by trypan blue staining. 
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Nuclei were spun down at 3500 rpm for 10 min at 4°C (pellet=nucleus 
fraction). The supernatant was centrifuged at lOOOOOXg for 30 min 
to pellet the cell membranes (membrane fraction). Lactase activity was 
measured in cell homogenates, membrane pellets and in the final 
supernatant according to Dahlqvist [9] using lactose as substrate. 
2.3. Cells and cell culture 
COS-1 cells were a generous gift from Dr. J. Kruppa (Hamburg). 
COS-1 cells were grown as monolayers in Eagle's minimal essential 
medium with Earle's salts (EMEM) supplemented with 10% (v/v) 
FCS, 100 mU/ml of penicillin and 100 ug/ml of streptomycin. 
MDCK-17 clone expressing human LPH permanently has been 
previously characterized [7]. To establish this cell clone, MDCK cells 
were cotransfected with pRB-lH containing the full-length cDNA for 
human LPH and pXTl containing the neor resistance gene for selec-
tion in geneticin-containing medium [7,10]. The transfected MDCK 
cells were grown as monolayers in Earle's minimal essential medium 
with Earle's salts (EMEM) supplemented with 5% (v/v) FCS and 400 
Ug/ml G418. The medium was changed every 2 days. The expression 
of the transgene was enhanced by culturing the cells overnight in 
medium containing 8 mM sodium butyrate. 
2.4. Transfection of COS-1 cells and biosynthetic labelling 
Low passage number (<25) of COS-1 cells were used for DEAE-
Dextran transfection. The method was as described by Cullen [11]. In 
brief, 1.5 X 106 COS-1 cells were seeded onto 100-mm dishes 24 h 
before transfection. The semi-confluent cells were transfected with 
1 ug of recombinant DNA (pRB-1) using DEAE-Dextran. pRB-lH 
contains the full-length cDNA for human LPH. The transfection pro-
cedure used included a chloroquine shock [12]. After transfection, cells 
were maintained in fresh medium. Cells were used 48-72 h post-trans-
fection. Prior to labelling, medium was removed and the cells were 
incubated for 1 h in cell culture medium, lacking methionine. Cells 
were either continuously labelled (different pulse times were used as 
indicated in the appropriate sections of the text) with 50 uCi of 
[35S]methionine, or pulse labelled first, followed by a chase for differ-
ent lengths of time in medium containing 10 mM non-radioactive L-
methionine. 
When used, BFA was added to cell cultures at a final concentration 
of 1-5 ug/ml. Inhibitor of lysosomal function was added 1 h before 
and during labelling at concentrations of 1-20 mM (NH4CI). 
2.5. Immunoprecipitation of human LPH 
Labelled COS-1 and MDCK cells were washed 3 times with 5 ml of 
ice-cold PBS and lysed by adding 1 ml of lysis buffer (25 mM Tris-
HC1, pH 8.0, 50 mM NaCl supplemented with 1% NP-40, 1% DOC, 
100 ug/ml PMSF, 10 ug/ml leupeptin, 2 ug/ml pepstatin, 34.8 ug/ml 
benzamidine, and 2 ug/ml aprotinin. The lysates were centrifuged at 
100 000 Xg for 30 min prior to immunoprecipitation. Solubilised 
membrane proteins were precleared twice with protein A-Sepharose 
beads and transferred to tubes with 100 ul of antibody-protein A-
Sepharose (containing 3 ul of the monoclonal antibody HBB 1/909/34/ 
74 against lactase [13]). After an incubation period of at least 2 h at 
4°C, beads were washed 3 times with 1 ml of PBS containing 0.5% 
NP-40, 0.05% DOC and 0.05% SDS and then twice with 125 mM 
Tris-HCl (pH 8.2), 500 mM NaCl, 1 mM EDTA, 0.5% NP-40. 
2.6. Surface immunoprecipitation 
COS-1 cells were grown in 60-mm dishes, transfected and labelled 
as described above. The cells were incubated for 30 min in serum-free 
EMEM before cell surface proteins were immunoprecipitated [14]. 
The cells were washed 4 times with ice-cold PBS (137 mM NaCl, 
2.7 mM KC1, 6.47 mM Na2HP04 , 1.47 mM KH 2P0 4 , pH 7.4). After 
washing the cells, 3 ul of the monoclonal antibody against lactase [13] 
in 1 ml of PBS were added in the medium. After 30 min incubation 
with gentle agitation at 4°C, the cells were washed 4 times with PBS 
and an excess of unlabelled cell protein from pRB-lH-transfected 
COS-1 cells in 1 ml of PBS were added to the cells to saturate the 
remaining free antibody binding sites. After 15 min at 4°C, cells were 
washed again with PBS, scraped and lysed in 1 ml of 25 mM Tris-HCl 
(pH 8.0), 50 mM NaCl buffer supplemented with 1% NP-40, 1% 
DOC, 100 ug/ml PMSF, 10 ug/ml leupeptin, 2 ug/ml pepstatin, 34.8 
ug/ml benzamidine, and 2 ug/ml aprotinin for 30 min on ice. After 
ultracentrifugation to remove cell debris the antigen-antibody com-
plexes were adsorbed to protein A-Sepharose and analysed by SDS-
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PAGE. To isolate intracellular protein solubilized cell extracts were 
subsequently immunoprecipitated a second time with the lactase anti-
body bound to protein A-Sepharose. 
2.7. Endoglycosidase H and endoglycosidase F-treatment (endo FIGF) 
Digestion of immuno-isolated LPH with endo H and endo F/GF 
was carried out as previously described [4]. Treated proteins were 
recovered by precipitation with 30% (w/v) trichloroacetic acid, 
washed, and kept at -20°C until analysed by SDS-PAGE together 
with undigested proteins. 
2.8. SDS-PAGE 
Immunoprecipitates and proteins subjected to endo H treatment 
were solubilized with 30 ul of 2-fold concentrated electrophoresis 
sample buffer containing 4% SDS, 20% glycerol, 5% 2-mercaptoefha-
nol or 5 ul of 2 M M-dithiothreitol, boiled for 4 min and submitted to 
electrophoresis on 6% acrylamide gels according to Laemmli [15]. The 
gels were stained with Coomassie blue R250, destained with 40% 
methanol/10% acetic acid, treated with sodium salicylate, and exposed 
to Kodak X-OMAT AR films at -80°C. 
3. Results 
3.1. Human LPH expressed in COS-1 cells is enzymatically 
active 
The activity of human LPH expressed in COS-1 cells was 
determined in cell homogenates and an enriched plasma mem-
brane-fraction. The specific activity of lactase was 5.9 and 
19.8 IU/g protein in the homogenate and the membrane frac-
tion respectively (n = 2). In comparison, specific activity in 
mucosal homogenates was 35 IU/g protein (« = 3), and in 
enriched microvillus membrane fractions it was 275 IU/g pro-
tein (n-2). The activity of lactase in the COS-1 cell mem-
brane fraction was enriched by a factor of 3.4. 100% of the 
activity in the homogenised transfected COS-1 cells was re-
covered in the membrane-fraction. These results clearly 
showed that the lactase expressed in COS-1 cells was enzy-
matically active and membrane bound. 
3.2. Lactase-phlorizin hydrolase expressed in COS-1 cells 
undergoes proteolytic processing 
Fig. 1A shows a pulse-chase labelling experiment with pRB-
1H transfected COS-1 cells. Expressed human LPH was syn-
thesized as a 210 kDa high mannose precursor molecule (pro-
LPHh). After 2 h of chase a complex glycosylated 220 kDa 
precursor form (pro-LPHc) appeared. These findings are con-
sistent with data obtained from small intestinal epithelial cells 
and endo H analysis (Fig. IB) [4]. A 145 kDa form corre-
sponding in size closely to mature LPH (m-LPH) was detect-
able after 5 h of chase. Upon longer chases, the ratio pro-
LPH/m-LPH decreased. This indicated that some proteolytic 
processing occurred in COS-1 cells resulting in the appearance 
of a molecular species similar in size to the mature LPH found 
in human intestine [4], Caco-2 [6] and transfected MDCK cells 
[7,16]. 
In Fig. IB human LPH expressed in COS-1 cells is com-
pared to that in human intestinal biopsies. As assessed by 
SDS-PAGE, pro-LPH synthesized in COS-1 cells (220 kDa) 
corresponded closely to the equivalent species synthesized in 
human intestinal biopsies (215 kDa). The processed form in 
COS-1 cells (145 kDa) showed somewhat different electropho-
retic properties to the mature form in human intestine (160 
kDa). Endo F treatment prior to SDS-PAGE in both cases 
yielded polypeptides with identical mobilities, indicating that 
mobility differences are due to differences in glycosylation. 
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Fig. 1. A: Biosynthesis and post-translational processing of LPH ex-
pressed in COS-1 cells. The cells were pulse-labelled 48 h post-trans-
fection for 1 h with 50 uCi/60 mm culture dish [35S]methionine, 
then chased for the indicated time points. Analysis was by SDS-
PAGE and fluorography. Exposure of the Kodak X-OMAT AR 
film was 4 h. Pro-LPHh = high-mannose form of the precursor mole-
cule with an apparent molecular mass of 210 kDa. Pro-LPHc = com-
plex glycosylated precursor molecule with an apparent molecular 
mass of 220 kDa. m-LPH = Putative mature 145 kDa form of LPH. 
0 = Mock transfected COS-1 cells pulse-labelled for 22 h and then 
treated as described above. C = LPH transfected COS-1 cells contin-
uously labelled for 23 h. B: Comparison of LPH expressed in COS-
1 cells and human intestinal explants. Transfected COS-1 cells and 
human intestinal explants were continuously labelled for 22 and 6 h, 
respectively with [35S]methionine. Immunoisolated LPH was split 
into two aliquots, one control and one sample which was treated 
with endo F and analysed by SDS-PAGE and fluorography. 
3.3. Brefeldin A arrests the proteolytic processing of pro-LPH 
in COS-1 cells 
As shown in Fig. 2, different concentrations of BFA pre-
vented the formation of 'mature' LPH after 7.5 h of chase. 
Furthermore, the effect of BFA was reversible, as m-LPH 
reappeared after a 21 h chase when the drug was removed 
from the culture medium during chase. These data clearly 
demonstrate a precursor/product relationship between the 
pro-LPH and the m-LPH in transfected COS-1 cells and cor-
relate well with data obtained using Caco-2 cells and intestinal 
explants [6], which demonstrated that proteolytic processing 
of pro-LPH occurred after passage of precursor through the 
Golgi complex. 
3.4. The proteolytically processed form of LPH is not found on 
the cell surface 
Using cell surface immunoprecipitation assays the surface 
expression of human LPH in COS-1 cells was investigated. 
The pulse-chase experiment summarised in Fig. 3 shows sur-
face expressed LPH on the left and intracellular LPH on the 
right. In addition, LPH species immuno-isolated after contin-
uous labelling of cells for 24 h are shown (lanes C). Two 
hours after the initiation of chase the complex glycosylated 
precursor form (pro-LPHc) appeared on the cell surface. The 
proteolytically processed form was not detectable on the cell 
surface. When lactase transfected COS-1 cells were labelled 
for 24 h, only traces of m-LPH and no pro-LPHj, were de-
tected on the cell surface (lane C, surface). These species were 
subsequently present in the total precipitate after surface im-
munoprecipitation (lane C, intracellular). The LPH immuno-
precipitated from the intracellular compartment showed an 
electrophoretic pattern identical to that shown in Fig. 1. 
The lack of m-LPH on the cell surface of transfected COS-1 
cells indicated a different proteolytic mechanism in these cells 
compared to intestinal epithelial cells. 
3.5. NH4Cl inhibits the proteolytic cleavage of pro-LPH 
expressed in COS-1 cells but not in MDCK cells 
To investigate possible lysosomal involvement in the pro-
0 13 7.5 21 [h] chase 
205 kDa 
116 kDa 
97 kDa 
pro-LPH 
"m-LPH " 
0 0 0 1 2 5 1 2 0 tig/ml BFA during pulse 
0 0 0 1 2 5 0 0 0 ug/ml BFA during chase 
Fig. 2. Effect of BFA on processing of LPH expressed in COS-1 cells. Transfected cells were labelled with 50 u,Ci [35S]methionine for 1 h in 
the absence or presence of different concentrations (ug inhibitor/ml medium) of BFA. 0 = mock transfected COS-1 cells labelled for 1 h and 
chased for 21 h in the absence of BFA. C = LPH transfected COS-1 cells continuously labelled for 21 h in the absence of BFA. Pro-LPH = pre-
cursor form of LPH; m-LPH = putative mature form of LPH. 
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205 kDa = P1"0"!^^ 
~ pro-LPHh 
— "m-LPH" 
116 kDa 
immunoprecipitation 
Fig. 3. Pulse-chase analysis and surface expression of LPH in COS-1 cells. After pulse-labelling for 1 h and subsequent chasing for 2, 5, 8, 23 h, 
surface expressed LPH was isolated by surface immunoprecipitation (see Section 2 for details). The remaining intracellular LPH was isolated 
by a further immunoprecipitation. 0 = mock transfected COS-1 cells labelled for 23 h, lysed and total immunoprecipitated. C = LPH transfected 
cells continuously labelled for 24 h, surface expressed LPH immunoprecipitated first followed by intracellular LPH. Pro-LPHc = complex glyco-
sylated form of precursor; pro-LPHh = high mannose glycosylated form of precursor; m-LPH = putative mature form of LPH. 
0 1mM 5mM 10mM 20mM ammoniumchloride 
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Fig. 4. Pulse-chase analysis in the presence of ammonium chloride. Panel A: LPH transfected COS-1 cells were pulsed for 1 h and chased for 
16 h in the presence of the indicated inhibitor concentrations. After chasing cells were lysed, LPH was immunoprecipitated and subjected to 
SDS-PAGE and fluorography. Exposure of the film was 2 days. C = LPH transfected COS-1 cells continuously labelled for 16 h in the absence 
of inhibitor. Panel B: The relative intensities of the signals on the fluorographs were quantified using a laser densitometer (Applied Biosystems) 
and the ratios of pro-LPH to m-LPH of COS-1 cells were depicted as histograms. For each time point pro-LPH+mature LPH = 100%. pro-
LPH (solid columns); mature LPH (hatched columns). Panel C: 16 h before labelling MDCK-17 cells were stimulated with sodium butyrate. 
MDCK-17 cells were then pulsed for 1 h and chased for 16 h in the presence of inhibitor identical to COS-1 cells. After chasing cells were 
lysed, LPH was immunoprecipitated and subjected to SDS-PAGE and fluorography. Exposure of the film was 2 days. C = LPH transfected 
MDCK-17 cells continuously labelled for 16 h in the absence of inhibitor. Panel D: The relative intensities of the signals on the fluorographs 
were quantified using a laser densitometer (Applied Biosystems) and the ratios of pro-LPH to m-LPH of MDCK cells were depicted as histo-
grams. For each time point pro-LPH+mature LPH = 100%. pro-LPH (solid columns); mature LPH (hatched columns). 
teolytic processing of LPH in COS-1 cells, we performed stud-
ies in which COS-1 cells were labelled for 1 h, followed by a 
chase of 16 h in the presence of ammonium chloride, a known 
inhibitor of lysosomal function [17]. The LPH species isolated 
from these cells are shown in Fig. 4, panel A. With increasing 
concentrations of inhibitor, the ratio of pro-LPH/m-LPH in-
creased (Fig. 4, panel B). 20 mM ammonium chloride totally 
abolished proteolytic processing of pro-LPH. In parallel con-
trol experiments, MDCK-17 cells, a cell line that permanently 
expresses human LPH, were pulsed and chased identically to 
transfected COS-1 cells above in the presence of the same 
concentrations of inhibitor. In contrast to COS-1 cells, the 
ratio of pro-LPH/m-LPH did not change with increasing con-
centrations of inhibitor in MDCK-17 cells (Fig. 4, panels C 
and D). From this finding, we conclude that the observed 
'mature' form of LPH in COS-1 cells was not the product 
of normal processing of LPH seen in intestinal epithelial cells 
and transfected MDCK cells but was the result of lysosomal 
degradation. 
4. Discussion 
Biosynthesis and post-translational processing of LPH has 
been the subject of intense investigations [2-4,6,8,16,18]. 
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A crucial step in the maturation of this enzyme is the pro-
teolytic conversion of the 215 kDa pro-LPH precursor to the 
160 kDa mature form. For human LPH, using biosynthetic 
studies in Caco-2 cells and intestinal explants in organ culture 
at low temperatures and in the presence of BFA, we have 
shown that proteolytic cleavage of pro-LPH is a post-Golgi 
event [6]. In heterologous expression studies of human LPH in 
MDCK cells we have furthermore been able to show that 
proteolytic processing was not required for correct sorting 
of the enzyme to the apical (microvillus) membrane [7]. The 
latter findings have subsequently been confirmed by Jacob et 
al. [16]. Recently, two independent studies demonstrated that 
proteolytic processing of human LPH involves two steps 
[19,20]. A first cleavage at Arg734-Leu735 occurring intracellu-
larly, which generates an intermediate form of 160 kDa. After 
insertion of the intermediate into the microvillus membrane 
the second and final processing taking place at Argg68-Ala869 
by luminal trypsin. 
Processing of LPH to the mature enzyme has been reported 
to be lacking in transfected COS-1 cells [8]. Hence these cells 
were thought to be an ideal cotransfection system for the 
study of potential processing enzymes in LPH-maturation. 
The findings reported here confirm other studies in that 
they show LPH to be synthesized by COS-1 cells in an enzy-
matically active form. The specific activity in the homogenate 
of transfected COS-1 cells was in the range previously re-
ported [8]. 
Furthermore, pulse-chase experiments led to the identifica-
tion in transfected COS-1 cells of a mannose-rich 210 kDa 
pro-LPHh species, which was converted into a complex-type 
220 kDa pro-LPHc species within 2 h of chase. This was in 
accordance to the molecular mass range reported by Nairn et 
al. [8] for COS-1 cells, and within the molecular mass range of 
LPH expressed in small intestinal epithelial cells [4]. 
Contrary to previous findings [8] we also observed a pro-
teolytically processed form of LPH in transfected COS-1 cells. 
This form appeared after 5 h of chase and was somewhat 
smaller (145 kDa) than the mature form found in intestinal 
epithelial cells (160 kDa). Deglycosylation by endo F/GF, 
however, reduced both species to an identical size of 122 
kDa, indicating that the differences are due to differences in 
the glycosylation status. Continuous biosynthetic labelling of 
transfected COS-1 cells resulted in the detection of amounts of 
this 'mature' LPH comparative to those found in intestinal 
biopsies. 
Previous failure to detect this processed LPH form may 
thus be explained by the shorter incubation times used in 
the biosynthetic labelling experiments. 
It can therefore not be unequivocally determined if the en-
zymatic activity detected in transfected COS-1 cells is due to 
active pro-LPH or to the processed form or both. 
The appearance of the processed m-LPH was inhibited by 
BFA. As BFA blocks intracellular protein transport to the cell 
surface, it is concluded that formation of this mature-like 
enzyme requires that pro-LPH is expressed on the plasma 
membrane of COS-1 cells. In contrast to other cell systems, 
the bulk of m-LPH was isolated from the intracellular com-
partment of transfected COS-1 cells. In addition, the complex 
glycosylated pro-LPH was predominantly detected as an ec-
toenzyme on the plasma membrane. These data suggest that 
in COS-1 cells pro-LPH is transported to the cell surface 
before being internalised again via the endocytic pathway 
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where it is proteolytically cleaved by lysosomal hydrolases. 
This idea is clearly supported by experimental data obtained 
with an inhibitor of lysosomal function. Addition of the lyso-
somotropic agent NH4CI led to the abolition of proteolytic 
processing. In rat hepatocytes, it has been shown that late 
endosomes contain a trypsin-like protease [21], which is able 
to process internalised proteins after a basic amino acid resi-
due like lysine. Pro-LPHc internalised into an endosomal-ly-
sosomal compartment was only processed to m-LPH. In vivo, 
m-LPH anchored to the microvillus membrane of the enter-
ocyte as an ectoenzyme is likewise not degraded further de-
spite the potentially hostile proteolytic environment of the gut 
lumen. One explanation for this proteolytic resistance of ma-
ture LPH is that due to the compact folding only a few po-
tential cleavage sites are exposed to the proteolytic enzymes of 
the gut. Support for this view comes from transfection studies 
with various LPH mutants. Only minor mutations in the 'pro' 
region of LPH resulted (a) in diminished complex glycosyla-
tion and thus a reduced transport competence and (b) in a 
complete degradation by trypsin (unpublished results). After 
the identification of the primary cleavage site in the two-step 
processing of human LPH [20] we suggest that the intermedi-
ate form of LPH plays an important role in the correct fold-
ing of this enzyme and that this leads to an relative resistance 
to proteolytic enzymes. 
The appearance of the m-LPH in transfected COS-1 cells, 
on the other hand, demonstrates the potential limitations of 
these cells in studies where proteolytic processing of newly 
synthesised proteins is concerned. 
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